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Episodic ataxia type 1 (EA1) is an autosomal dominant K+ channelopathy which
manifests with short attacks of cerebellar ataxia and dysarthria, and may also show
interictal myokymia. Episodes can be triggered by emotional or physical stress, startle
response, sudden postural change or fever. Here we describe a 31-year-old man
displaying markedly atypical symptoms, including long-lasting attacks of jerking muscle
contractions associated with hyperthermia, severe migraine, and a relatively short-sleep
phenotype. A single nucleotide change in KCNA1 (c.555C>G) was identified that
changes a highly conserved residue (p.C185W) in the first transmembrane segment
of the voltage-gated K+ channel Kv1.1. The patient is heterozygous and the mutation
was inherited from his asymptomatic mother. Next generation sequencing revealed no
variations in the CACNA1A, CACNB4, KCNC3, KCNJ10, PRRT2 or SCN8A genes of either
the patient or mother, except for a benign variant in SLC1A3. Functional analysis of the
p.C185W mutation in KCNA1 demonstrated a deleterious dominant-negative phenotype
where the remaining current displayed slower activation kinetics, subtle changes in
voltage-dependence and faster recovery from slow inactivation. Structural modeling also
predicts the C185W mutation to be functionally deleterious. This description of novel
clinical features, associated with a Kv1.1 mutation highlights a possibly unrecognized
relationship between K+ channel dysfunction, hyperthermia and migraine in EA1, and
suggests that thorough assessments for these symptoms should be carefully considered
for all patients affected by EA1.
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INTRODUCTION
Episodic ataxia type 1 (EA1) is an autosomal dominant K+
channelopathy which manifests as brief episodes of cerebellar
dysfunction with paroxysmal ataxia, dysarthria, diplopia, vertigo
and tremor often lasting for seconds or minutes. Some patients
also show interictal myokymia. Additional ictal symptoms may
comprise spastic contractions, stiffening of the body, visual dis-
turbances, seizures and mild headache (VanDyke et al., 1975).
The episodes can be triggered by emotional or physical stress,
startle response, sudden postural change, and even caffeine. Fever
or high temperatures occurring after a hot bath have also been
reported to precipitate attacks (Eunson et al., 2000; Klein et al.,
2004). The onset of symptoms is typically within the first or sec-
ond decade of life and the frequency of attacks can vary from less
than once per month to 30 times a day.
The disorder results from loss-of-function mutations in the
KCNA1 gene which encodes the voltage-gated K+ channel, Kv1.1
(Browne et al., 1994; Adelman et al., 1995; D’Adamo et al., 1998;
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Imbrici et al., 2003, 2006, 2007, 2011; Cusimano et al., 2004;
Pessia et al., 2012). Most individuals with EA1 have a pedigree
suggestive of autosomal dominant inheritance with at least one
affected family member. However, one de novo mutation has also
been reported (Demos et al., 2009). Diagnosis is primarily based
on clinical findings and molecular genetic testing of KCNA1, and
these investigations in several affected families have broadened
the clinical spectrum of EA1 to now include phenotypes with
delay in motor development, choreoathetosis, cognitive dysfunc-
tion, transient postural abnormalities in infancy, shortening of
the Achilles tendon in children and epileptic seizures (Zuberi
et al., 1999; Demos et al., 2009; D’Adamo et al., 2012, 2013;
Pessia et al., 2012). Electromyographic myokymia can be con-
firmed in nearly all individuals with EA1, but in some cases
the myokymic activity only becomes apparent after application
of regional ischemia. Mutations in KCNA1 are also known to
be associated with isolated neuromyotonia (Eunson et al., 2000;
Kinali et al., 2004). Moderate muscle hypertrophy, a generalized
increase in muscle tone and bilateral calf hypertrophy have also
been reported for EA1 patients (VanDyke et al., 1975; Kinali et al.,
2004; Demos et al., 2009). Recently, direct evidence identified the
motor nerve as an important generator of myokymic activity and
showed that dysfunction of juxtaparanodal Kv1.1 channels alters
Ca2+ homeostasis inmotor axons (Brunetti et al., 2012; D’Adamo
et al., 2014). In a large Brazilian family harboring a KCNA1
mutation, low blood levels of magnesium with recurrent muscle
cramps, tetanic episodes, limb muscle weakness and electromyo-
graphic myokymia were also found (Glaudemans et al., 2009).
Since Kv1.1 channels are widely expressed in the nervous system,
particularly in the cerebellum, hippocampus and hypothalamus
(Albrecht et al., 1995; Geiger and Jonas, 2000; Herson et al., 2003),
it is therefore perhaps not so surprising that EA1 patients exhibit
such a variable clinical phenotype (Graves et al., 2010).
In this study, we now describe a 31-year-old man carry-
ing a dominant-negative, loss-of-function mutation in KCNA1
who displays a new phenotype characterized by episodes of
hyperthermia, short-sleep duration, and severe migraine.
MATERIALS AND METHODS
GENETIC ANALYSIS
Patients were studied after giving informed consent and investi-
gations were conducted in accordance with protocols approved
by the institutional review boards of the Friedrich-Baur-Institute
of the Ludwig-Maximilians-University, Munich, Germany. DNA
was isolated from the peripheral blood by standard methods. The
coding regions and exon-intron boundaries of KCNA1 were PCR
amplified using primer oligonucleotides designed with the Primer
Express tools. PCR conditions are available upon request. Direct
sequencing of KCNA1 was performed using an automated Sanger
dideoxy method.
ELECTROPHYSIOLOGY
The human Kv1.1 cDNA was subcloned into the pBF oocyte
expression vector. The p.C185W mutation was introduced by
site-directed mutagenesis and verified by automated sequenc-
ing. The concentration of in vitro transcribed cRNA was quan-
tified by electrophoresis and ethidium bromide staining, and
spectrophotometric analysis. Expression of wild-type and mutant
channels in Xenopus laevis oocytes and two-electrode voltage-
clamp recordings (TEVC) and patch-clamp recordings were per-
formed as previously described (D’Adamo et al., 1998). Briefly,
TEVC recordings were performed from oocytes at ∼22◦C and
1–8 days after cRNA injection by using a GeneClamp 500 ampli-
fier (Axon) interfaced to a PC computer with an ITC-16 interface
(Instrutech Corp., USA). Microelectrodes were filled with 3M
KCl and had resistances of 0.1–0.5M. The extracellular solution
contained (mM): NaCl 96, KCl 2, MgCl2 1, CaCl2 1.8, HEPES 5,
pH 7.4. Recordings were filtered at 2 kHz and acquired at 5 kHz
with Pulse software and analyzed with either PulseFit (HEKA,
Germany) or Origin 8 program. Leak and capacitative currents
were subtracted using a P/4 protocol. Kinetic parameters were
evaluated from current amplitudes <10μA using low resistance
electrodes.
Patch-clamp recordings were performed with an Axopatch
200B amplifier (Axon Instruments). The pipette solution con-
tained (mM): NaCl 120, KCl 2, HEPES 5, pH 7.4 whereas the
cytoplasmic solution contained (mM): KCl 120, EGTA 1, HEPES
5, pH 7.4. Recording electrodes were pulled from borosilicate
glass, coated with Sylgard and had resistances of 5–15 M.
The excised inside-out patch recordings were low-pass filtered at
0.5–2 kHz with an 8 pole bessel filter (Frequency Devices, MA)
and acquired with a Pulse + PulseFit program (HEKA elektronik
GmbH, Germany). Channel activity was analyzed with a TAC-
TACfit program (Bruxton Co. WA), by inspecting all transitions
and their slope conductance was assessed at different potentials
from all events histograms.
Xenopus laevis were deeply anesthetized with an aerated solu-
tion containing 3-aminobenzoic acid ethyl ester methanesul-
fonate salt (5mM) and sodium bicarbonate (60mM), pH 7.3.
Stage V–VI Xenopus oocytes were isolated, injected with 50 nl
RNA and stored at 16◦C in fresh ND96 medium containing
(mM): NaCl 96, KCl 2, MgCl2 1, CaCl2 1.8, HEPES 5, gen-
tamicin 50μg/ml. Xenopus laevis underwent no more than two
surgeries, separated by at least 3 weeks. Animal handling and elec-
trophysiological experiments were conducted in accordance with
international standards on animal care, and the regulations of
the Italian Animal Welfare Act, approved by the local Veterinary
Service Authority, and with the NIH Guide for the Care and Use
of Laboratory Animals.
HOMOLOGY MODELING
A 3D structural model of Kv1.1 was built through compara-
tive modeling using the software Modeler (Sali and Blundell,
1993) and the crystal structure of the Kv1.2/2.1 chimera (PDB
id.: 2R9R) as a template (Nishida et al., 2007). Sequence align-
ment of the target sequence vs the template was generated using
ClustalX, and further refined using Muscle (Edgar, 2004). Twenty
homology models were generated and scored against the min-
imum number of constraint violations. Among them, the five
lowest energy models were selected and analyzed using Procheck
(Laskowski et al., 1996). The final model was chosen according
to the highest percentage of residues in the allowed region of the
Ramachandran plot (N90%). The model was then immersed in
a pre-equilibrated palmitoyl-oleoyl-phosphatidylcholine (POPC)
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FIGURE 1 | (A) Pedigree of the family of the patient (II.2). (B) Sequence
analysis of the KCNA1 gene mutation. DNA sequence from the patient (p;
II2) and a control individual (c). The upper sequencing profile shows the
heterozygous single nucleotide change at position c.555C > G, which leads
to a cysteine (C) to tryptophan (W) substitution (p.C185W) in the protein
Kv1.1.
lipid bilayer, and all overlapping lipid molecules (within 3 Å from
any protein atoms) removed. The final model was further mini-
mized to reduce steric hindrance with neighboring atoms using
GROMACS4 and the GROMOS96 forcefield (Hess et al., 2008).
RESULTS
CASE REPORT
The proband (II.2, Figure 1A) is a 31-year-old man who has been
suffering from episodes of ataxia, dysarthria, diplopia and oscil-
lopsias from childhood. The frequency of his attacks was mostly
low (1–2 per week or less). Typical episodes lasted 2–3min,
were triggered by physical exercise and sudden movements, but
not by alcohol or caffeine. Attacks were also precipitated by
febrile illnesses. However, several episodes witnessed in-hospital
were characterized by ataxia/dysarthria, lasting for hours and
days, with concurrent hyperthermia up to 40.3◦C that was
not caused by an obvious focus of infection with the excep-
tion of streptococcal tonsillopharyngitis being detected in one
episode.
With regard to his sleeping habits, the patient reported that he
has always been quite active at night and had chosen to work as a
night watchman. He also reported that 5–6 h of sleep were typi-
cally sufficient. Polysomnography was unremarkable (sleep stages
N1, N2, N3 and REMwithin normal ranges, sleep latency 42min,
REM latency 56min, apnea-hypopnea index 3, mean SaO2
95.4%, min SaO2 90.5% with a total sleep time being 376.6min.
No periodic leg movements or apneas were detected. The obser-
vations prompted us to investigate the sleeping habits in another
EA1 patient, whose clinical case had been described previously
(Imbrici et al., 2008). Interestingly, this patient also reported
that just 5–6 h of sleep was sufficient although polysomnography
analysis was not performed.
The proband (II.2) has suffered from severe migraine since
childhood and these attacks manifested with hemicrania, nau-
sea, photo-, and phonophobia lasting for 4–5 h. Most of migraine
attacks occurred independently from ataxia, although in some
instances both symptoms manifested at the same time. The clin-
ical interictal examination of the patient was completely normal;
in particular there was no myokymia, ataxia, dysarthria or ocu-
lomotor abnormalities. Electromyography without application of
regional ischemia of the right biceps brachii, right abductor digiti
minimi and left orbicularis oris muscles revealed nomyokymia or
other abnormalities. Except for a mild increase of serum osmolal-
ity, laboratory tests were normal and no abnormalities of sodium,
potassium, calcium, magnesium and phosphate in blood and
urine were found. Brain MRI revealed no evidence of circum-
scribed atrophy, and the proband was treated with acetazolamide,
but this therapy had to be stopped due to tiredness. Neither of
the patient’s parents, aged 48 (mother, I.1) and 54 (father, I.2)
years, nor his two brothers (aged 30, II.1 and 16, II.3 years), or his
two sons (aged 5, III.1 and 3, III.2 years) and daughter (aged 1,
III.3 year) suffered from similar episodes of ataxia or dysarthria
(Figure 1A).
GENETIC ANALYSIS
Despite a negative family history, direct sequencing was per-
formed that revealed a single nucleotide change in KCNA1 at
position c.555C > G (Figure 1B). The resulting p.C185W muta-
tion, which changed a highly conserved residue located in the
first transmembrane segment (S1) of Kv1.1, has been previ-
ously reported (Tomlinson et al., 2013). This heterozygous muta-
tion was inherited from his mother, who nevertheless, appeared
asymptomatic. Thus, to further associate this unusual pheno-
type with the c.555C > G mutation in KCNA1, next genera-
tion sequencing (NGS) of all known EA genes was performed.
The panel comprised the following genes: CACNA1A, CACNB4,
KCNA1, KCNC3, KCNJ10, PRRT2, SCN8A, and SLC1A3. This
analysis confirmed the presence of the KCNA1 c.555C > Gmuta-
tion in the index patient and his asymptomatic mother. The
only other sequence change found among the EA genes men-
tioned above was a c.1559A > G, p.K520R change in the SLC1A3
gene of both the index patient and his asymptomatic mother.
However, bioinformatics analysis suggested that p.K520R was a
benign variant (PolyPhen-2: benign variant; SIFT: benign vari-
ant; Mutation Taster: pathogenic variant). These findings indicate
that the c.555C > G, p.C185W mutation in KCNA1 is likely to
be causative in this patient and suggest that the asymptomatic
status of his mother may be due to low penetrance of the
mutation.
FUNCTIONAL ANALYSIS OF Kv1.1 C185WMUTATION
KCNA1 encodes the pore-forming subunit of the voltage-gated
Kv1.1 potassium channel. The channel assembles as a tetramer
and each subunit contains six transmembrane segments (S1–S6).
Both wild-type and C185W mutant channels were expressed
in Xenopus oocytes and whole-cell currents recorded by TEVC
to assess possible differences in the expression levels caused by
the mutation. Expression of the homomeric C185W mutant
channel resulted in either no measurable functional channel
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FIGURE 2 | The C185W mutation results in non-functional homomeric
channels and exerts a dominant negative effect on WT channels.
(A1–3) Sample current families recorded from oocytes expressing the
indicated channels. Outward currents were evoked by 200ms depolarizing
commands from a holding potential of −80mV. (B) Representative bar
graph showing the average whole-cell current recorded at +60mV from
oocytes injected with WT cRNA (2 ng, left column), co-injected with WT
and C185W cRNAs (1 ng WT + 1ng C185W, central column) or C185W
cRNA (2 ng, right column). Similar results were obtained from several
independent experiments carried out using different batches of oocytes (not
shown). Data are mean ± SEM of 20–50 cells. The statistical significance
was determined by using an unpaired Student’s t-test (∗∗P < 0.001).
activity, or current amplitudes barely above the background
(Figures 2A3, B). By marked contrast, expression of wild-type
Kv1.1 (WT) gave rise to typical delayed-rectifier K+ currents of
large current amplitudes (Figures 2A1, B; cf. Figure 1 in D’Adamo
et al., 1998).
The proband was heterozygous for the p.C185Wmutation and
thus both normal and mutant alleles can be expressed. We there-
fore examined whether channels composed of a mixture of WT
and mutant subunits might be formed. Equal amounts of WT
and mutant RNAs were co-injected into the same oocyte and the
average current amplitudes then compared with those calculated
from cells injected with an equivalent amount of WT RNA. The
co-injection of WT and C185W RNAs (1:1 ratio) resulted in a
markedly reduced average current amplitude, that was ∼13% of
the control WT current measured at +60mV (Figures 2A2, B).
Taken together these findings clearly demonstrate that in a homo-
meric channel the p.C185W mutation causes a near complete
loss of function, and also exerts a dominant negative effect when
combined with WT channels as would be observed in the het-
erozygous state.
Kv1.1 and Kv1.2 subunits are co-localized in several sub-
cellular brain regions important for the control of movement
(e.g., juxtaparanodal regions of myelinated axons and cerebel-
lar Basket cell terminals). These subunits heteromultimerize to
form channels whose function are also markedly altered by EA1
mutations (D’Adamo et al., 1999). Consistent with this, we also
found that co-expression of Kv1.2 with C185W RNAs (1:1 ratio)
resulted in whole-cell current that was ∼20% of the control
WT, at +60mV (WT: 27.1 ± 3.2μA; WT + C185W: 5.4 ±
0.6μA; C185W: 0.8 ± 0.2μA; n = 6). This demonstrates that the
C185W mutation also exerts a dominant negative effect on Kv1.2
channels.
We next focused our investigations on the functional effects
of the p.C185W mutation in heteromeric WT/C185W channels.
cRNAs for both subunits were co-injected (1:1 ratio) into oocytes.
This results in a mixed population of channels where the con-
tribution of non-functional homomeric C185W channels will
be negligible whilst functional homomeric WT channels will
account for <7% of the channels present. This view is consis-
tent with previous studies demonstrating that EA1 mutations,
which do not alter surface expression of the protein (e.g., C185W;
Tomlinson et al., 2013), predominantly form heteromeric chan-
nels (Imbrici et al., 2011).
Whole-cell currents were recorded using tailored voltage-
clamp protocols (Figure 3) and the activating/deactivating cur-
rent traces of either WT or WT/C185W channels were fitted
with double- and single-exponential functions, respectively. The
calculated time constants were then plotted as a function of
membrane potential (Figures 3A,B). This analysis revealed that
currents resulting from WT/C185W channels had slower kinet-
ics of activation (Figures 3A,B), whereas the kinetics of deac-
tivation were slightly faster (Figures 3A,B). To determine the
voltage-dependence of WT/C185W current activation, tail cur-
rent families were recorded at −50mV after pre-pulse commands
to several voltages (Figure 3C). The Boltzmann fit to either WT
or WT/C185W tail current-voltage data points, revealed that the
midpoint activation voltage (V1/2) for the WT/C185W current
was unchanged (WT: −28.9 ± 0.5mV; WT/C185W: −28.1 ±
0.5mV; p > 0.05; Figure 3D). However, the slope factor k calcu-
lated from the Boltzmann fit of tail currents was slightly decreased
by the mutation (WT: 6.9 ± 0.3mV; WT/C185W: 5.1 ± 0.3mV;
p < 0.05; Figure 3D).
WT channels are characterized by a slow process of inac-
tivation named C-type inactivation that increases progressively
during intense neuronal activity, modifying both the firing rate
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FIGURE 3 | Effects of the mutation on activation/deactivation kinetics
and voltage-dependence of heteromeric channels. (A) Representative
current trace recorded at +60mV for WT channels, overlain with that
resulting from the co-injection of WT + C185W cRNAs (1:1). (B) The
activating and deactivating current traces were fitted with a double and single
exponential function, respectively, in order to assess the effects of the
C185W mutation on the activation and deactivation kinetics of the channel.
The relevant time constants for the WT (•), WT/C185W (◦; 1:1 ratio) channels
were calculated and plotted as a function of the test pulse in (B). This plot
shows that the mutation affects channel activation (τfast) which can be
directly observed also from (A). (C) Sample tail current families for the
indicated channels recorded at −50mV, after 200ms pre-pulse commands
from −80mV to 60mV (HP = −80mV; Vincrement = 10mV, inset). Note
that although tail currents for WT/C185W channels are significantly smaller
than the WT (see calibration bars) the relative current amplitudes, after a
pre-pulse potential to −30mV (arrows) are similar, denoting that both channel
types have analogous V1/2 values. (D) The voltage-dependence of channel
activation was determined by normalizing tail current-voltage data points for
WT (•) or WT/C185W (◦; 1:1 ratio) and by calculating the V1/2 and slope factor
k from fits with the Boltzmann function I = 1/1 + exp{–(V – V1/2)/k} (solid
curves). Notice that the mutation increases the steepness of the
voltage-dependence of heterozygous channels.
and the shape of the action potentials (Aldrich et al., 1979).
Thus, possible modifications of this distinct channel property
may be of pathogenic relevance for EA1. Slow inactivation was
estimated by fitting the time course of current decay with double-
exponential functions and calculating the fast (τfast) and slow
(τslow) time constants and relevant amplitudes by using the equa-
tion: Afast(%) = Afast/(Afast+Aslow) × 100. This analysis shows
that the τfast for heteromeric WT/C185W channels is slightly
slower than the WT (Figures 4A,B). By contrast, the τslow is not
statistically different (WT: τ = 34.8 ± 2.0 s, amplitude = 64%;
WT/C185W: τ = 30.6 ± 1.2 s; amplitude = 73%; p > 0.05).
Remarkably, WT/C185W channels display a much faster recov-
ery from slow inactivation than the WT (Figures 4C–F). These
results therefore suggest that this mutation destabilizes the slow
inactivated state.
To examine the effects of the p.C185W mutation at the single-
channel level, inside-out patch-clamp recordings were performed
from oocytes expressing WT or WT/C185W subunits (Figure 5).
The single channel slope conductance was unchanged by the
mutation (WT: 10.8± 0.6 pS; WT/C185W: 11.2± 0.5 pS; n = 4).
Moreover, the open-probability calculated at +20mV was also
unchanged (WT: 0.877 ± 0.022; WT/C185W: 0.882 ± 0.031;
p = 0.9).
In summary, this detailed functional analysis shows that
the C185W mutation: (i) causes a nearly complete loss-of-
function in homomeric channels; (ii) exerts a severe dominant-
negative effect on WT current amplitudes, and (iii) has
significant effects on the gating parameters of WT/C185W
currents.
STRUCTURAL CONSEQUENCES OF THE p.C185WMUTATION
To investigate possible structural defects associated with this
mutation, we used the crystal structure of the Kv1.2/2.1 chan-
nel (Long et al., 2007) to generate a homology model of
Kv1.1. Residue C185 in Kv1.1 resides in the S1 segment of
the voltage-sensor domain (Figure 6A). Also when mutated
in silico to a tryptophan the side-chain sterically clashes with
the pore-helix domain of the adjacent subunit (Figure 6)
and is therefore likely to be highly deleterious to channel
function.
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FIGURE 4 | Effects of the C185W mutation on slow inactivation. (A)
Normalized current traces resulting from either the expression of WT alone
or from the co-expression of WT and C185W cRNA at 1:1 ratios. To
determine slow inactivation kinetics, a test pulse to +60mV for 3.5min
was delivered to oocytes expressing WT and WT/C185W channels and the
decaying phase of the current fitted with a double-exponential function
from which the time constants were calculated. (B) Bar graphs showing the
fast time constants of the slow inactivation for the indicated channels (left
y-axis) and the relevant amplitude of time constants (right y-axis). These
results show that the mutation slightly slows-down the inactivation kinetics
of WT/C185W channels. (C1,C2) Sample current traces evoked by the
two-pulse protocol for the indicated channels. The recovery from slow
inactivation was determined for either WT (C1) or WT/C185W (C2)
channels by using a double-pulse protocol to +60mV, separated by
inter-pulse intervals of increasing duration (range: 0.010–21.87 s). The
current amplitudes evoked by the second pulse (test) were divided by the
first pulse (conditioning), normalized and plotted in (D) as a function of the
interpulse interval. The solid curves in (D) indicate the fit of the data points
with a double-exponential function from which the time constants were
calculated for WT (•) or WT/C185W (◦; 1:1). Bar graphs showing the fast (E)
and slow (F) time constants for the recovery from slow inactivation for the
indicated channels (left y-axis) and the relevant amplitude of time constants
(right y-axis). Note that the mutation speeds-up the recovery from
inactivation. A careful evaluation of the biophysical properties of homomeric
C185W channels was not possible due to marked current reduction. The
amplitudes of the time constants were calculated by using the equation:
Afast(%) = Afast/(Afast+Aslow) × 100. Data are means ± SEM of 10–15 cells.
Student’s t-test: ∗, P < 0.05; ∗∗P < 0.001.
DISCUSSION
Here we describe a single nucleotide mutation that changes a
highly conserved residue in the S1 segment (p.C185W) of the
Kv1.1 channel subunit in a proband affected by EA1. The muta-
tion produces marked effects on both the channel structure
and function, which most likely underscore the several atypical
symptoms displayed by the patient. First, we witnessed several
FIGURE 5 | Analysis of single-channel currents. Representative
single-channel currents recorded in the inside-out configuration of the
patch-clamp from oocytes expressing WT (A) and WT/C185W (B) channels.
The openings were evoked by 200ms depolarizing voltage commands to
+20mV from a holding potential of −80mV. Channel openings are up-ward
deflections and arrows denote closed (C) and open (O) levels. Current
traces were filtered at 0.5 kHz. Averaged sweeps with no openings were
used to subtract leak and capacity currents. (C, D) Single-channel currents
recorded from oocytes injected with WT (C) or WT/C185W (D) cRNAs and
evoked by voltage-ramps of 1000ms duration, from −80mV to +40mV.
The single-channel current-voltage relationships were calculated from fits of
the open state (dashed lines in C and D) which yielded 11.4 pS and 10.9 pS
for WT and WT/C185W, respectively. (E) Single-channel current amplitudes
calculated at several voltages from 4 different patches pulled from oocytes
injected with WT (•) or WT/C185W (◦; 1:1) cRNAs. Note that also these
single-channel slope conductance calculations from all event histograms
showed no differences between WT (10.8 pS) or WT/C185W (11.2 pS). Data
are means ± SEM of 4 patches.
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FIGURE 6 | Homology modeling of the C185W channel. (A, B) Side
stereoviews of a ribbon representation of the pore region (red ),
voltage-sensor (blue) and of the T1 domain (gray ) of the channel. The pictures
show only two monomers side by side for clarity. The location of the C185
residue (A) and of the C185W mutation (B) in the S1 helices are highlighted
as Van der Waals spheres (green). Close-up views of the C185 residue (C,
green sticks) and of the C185W mutation (D, green sticks) from top, showing
their molecular interactions with the P α-helix of the adjacent subunit. The
location of the salt-bridge between Glu187 (green) and Arg298 (orange) is
also highlighted as a red dashed line.
episodes of hyperthermia in our proband without an apparent
focus of infection. Although spontaneous myokymia was absent
in our patient, the episodes of hyperthermia were associated
with long lasting attacks of jerking muscle contractions. Thus, a
possible explanation for the observed hyperthermia is that such
prolonged muscle activity could be responsible for the abnor-
mal rises in body temperature. Exposure to warm temperature
has been reported to provoke attacks of ataxia (Eunson et al.,
2000; Klein et al., 2004). There are also anecdotal reports of cold
temperatures exacerbating symptoms in EA1 patients, which led
to the suggestion of temperature extremes triggering EA1 symp-
toms (Demos et al., 2009).More recently, in Kv1.1 knock-in ataxic
mice, spontaneous myokymic activity has been shown to be exac-
erbated by several types of stimuli including low temperature
(Brunetti et al., 2012). Notably, the neuromuscular transmission
of EA1 individuals and of animal models of EA1 is temperature
sensitive, and attacks of ataxia may be brought on by fever or a hot
bath (Tomlinson et al., 2013; D’Adamo et al., 2014). Altogether,
this evidence poses the question as to whether loss-of-function
mutations in Kv1.1 channels may be responsible for abnormal
raises in body temperature by altering the activity of distinct CNS
and PNS circuits. Indeed, possible sources of this thermoregu-
latory defect are hypothalamic neurons that mediate rapid core
body temperature changes. Interestingly, these neurons normally
express Kv1.1 channels which, if mutated, might produce such
effects (Albrecht et al., 1995; Rhodes et al., 1996). In addition,
the involvement of distinct subpopulation(s) of peripheral nerves
that transmit temperature signals and which also express Kv1.1
channels cannot be excluded (Tsantoulas and McMahon, 2014).
Another atypical symptom, not previously described, concerns
the sleeping habits of the patient who reported to need only
5–6 h per day. Interestingly, similar sleeping habits were found
in another EA1 patient we have previously investigated (Imbrici
et al., 2008). Most people sleep 7–8 h per night, although, a few
perform apparently well with just 3–4 h of sleep. This pheno-
typic trait seems to run in families, although the underlying genes
remain unclear. It is interesting to note that mutant mini-sleep
Drosophila, which sleep ∼70% less than WT flies, also carries
a loss-of-function point mutation in the Shaker (Kv1.1) gene.
This mutation also occurs in the S1 domain of the Drosophila
Kv1.1 ortholog, just three residues beyond the p.C185W muta-
tion (Cirelli et al., 2005). Moreover, mice lacking the Kcna2 gene,
encoding for the Shaker-related Kv1.2 channel, also have reduced
non-rapid eye movement (NREM) sleep and die early (Douglas
et al., 2007). Both Kv1.1 and Kv1.2 can form heteromeric chan-
nels in several brain regions, including those involved in sleep-
wake rhythm. Moreover, a number of studies have shown that
heteromeric Kv1.1/Kv1.2 channels play an important role in
the control of neuronal excitability, action potential propaga-
tion and synaptic transmission. Previously, we have shown that
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dominant-negative EA1 mutations can affect the function of
heteromeric Kv1.1/Kv1.2 channels (D’Adamo et al., 1999). Here
we also demonstrate that C185W markedly reduces the func-
tional activity of Kv1.2 channels. Thus, although polysomnog-
raphy analysis of the proband was borderline, a role for these
channel types in the neuronal processes that control sleep in
humans cannot be entirely excluded. Indeed, it is possible that
other EA1 patientsmay display an unrecognized short-sleep dura-
tion trait which, if confirmed, could represent the first evidence
showing a human K+ channel-dependent alteration in sleep
behavior.
Headache is also a symptom over-represented in EA1 indi-
viduals. Nevertheless, the presence of long-lasting episodes of
severe migraine characterized by nausea, photo- and phonopho-
bia, occurring independently of attacks of EA1, also demonstrate
that our probands’s symptoms do not fall within the spectrum
previously reported for KCNA1 mutations.
Owing to a noticeable intrafamilial and interfamilial pheno-
typic variability, genotype-phenotype correlations for EA1 can
often be difficult to establish reliably. Indeed, striking differences
in severity and frequency of EA1 attacks have been reported even
in identical twins (Graves et al., 2010). Thus, the asymptomatic
status of the proband’s mother and the lack of myokymia in the
index patient, although unusual, could be due to low penetrance
of the mutation or other epigenetic factors.
STRUCTURAL AND FUNCTIONAL IMPLICATIONS
Our structural model shows that the C185W mutation is located
very close to a highly conserved salt-bridge (R298/E187 in Kv1.1),
occurring between the S1 segment and the S4 helix, which rep-
resents the main voltage-sensor of the channel. This interaction,
in the Kv1.2/2.1 chimeric channel, has been shown to be impor-
tant for the control of voltage-dependent gating (Tao et al., 2010).
Indeed, these conclusions are also consistent with the tryptophan-
substitution mutagenesis of a Kv1.1 channel ortholog (Shaker)
performed by Hong and Miller, who showed that the C245W
mutation (equivalent to C185W) alters the voltage-dependence
and stabilizes the closed-state of homomeric channels (Hong and
Miller, 2000). On the other hand, our structural modeling sug-
gest consistency between the C185W-induced perturbation of
the pore-helix and the observed loss-of-function effect, possibly
via steric-dependent stabilization of the closed-state in homo-
meric channel. Severe trafficking defects, underlying the almost
complete loss-of-function of homomeric C185W channel, appear
unlikely because the mutant protein traffic normally to plas-
mamembrane when expressed in the human HEK293 cell line
(Tomlinson et al., 2013). The structural location of C185W is also
coherent with its effects on slow inactivation, a process thought to
involve conformationalmovements of the external pore and selec-
tivity filter (Grissmer and Cahalan, 1989; Stuhmer et al., 1989;
Hoshi et al., 1991; Pardo et al., 1992; Lopez-Barneo et al., 1993;
Baukrowitz and Yellen, 1995; Molina et al., 1997; Pessia, 2004;
González et al., 2012). In particular, the faster recovery from inac-
tivation indicates that the C185W substitution destabilizes the
slow inactivated state.
From a neurophysiological perspective, such faster kinetics
of recovery from inactivation would render Kv1.1 expressing
neurons more readily re-excitable by decreasing the refractory
period of action potentials. This would further exacerbate neu-
ronal hyper-excitability induced by the mutation in the heterozy-
gous state.
In conclusion, we report a new EA1 phenotype characterized
by hyperthermia associated with long lasting attacks of ataxia and
severe migraine. Detailed genetic and functional analysis of this
mutant allele are consistent with a pathogenic role for thisKCNA1
mutation. These results therefore indicate that a thorough assess-
ment for hyperthermia, short-sleep trait and migraine should be
carefully considered for all patients affected by EA1.
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